Delivery Order SPE2DR25D2205-SPE2DR26F2U39

The Defense Logistics Agency issued a $1,471.48 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for Belbuca 750 mcg film (60-count) with ultimate completion by April 23, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and vaccines to Defense Health Agency and...

<p>The Defense Logistics Agency issued a $1,032.99 delivery order to AmerisourceBergen Drug Corp on April 21, 2026, for Belbuca 150 microgram film (60-count).</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure and no set-aside designation. Ultimate completion date is April 22, 2026.</p>

<p>The Defense Logistics Agency issued a $1,027.72 delivery order to AmerisourceBergen Drug Corp on April 15, 2026, for Belbuca 150 mcg film (60 count).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of April 16, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $1,216.62 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for Belbuca 750 mcg film, 60s under a DLA Troop Support Medical indefinite delivery contract.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of April 21, 2026. No set-aside applies.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 9, 2026, with a ceiling value of $1,149.31 for supply of Belbuca 750 microgram film in 60-count quantities.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 10, 2026. The order carries firm fixed-price pricing under a no-set-aside competitive award.</p>

<p>The Defense Logistics Agency issued a $2,287.62 delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Belbuca 750 MCG film, 60 count.</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of February 27, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 9, 2026, for Belbuca 300 mcg film 60s with a ceiling value of $1,432.68.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is April 10, 2026. The order is firm fixed price and carries no set-aside.</p>

On January 28, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,072.42 to AmerisourceBergen Drug Corp for the supply of Belbuca 900 microgram film (60-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The place of...

The Defense Logistics Agency awarded a $2,693.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 units of Belbuca 300 mcg film on November 13, 2025, with completion expected by November 14, 2025. This non-set-aside award represents a pharmaceutical supply delivery to support federal medical procurement needs. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 25, 2026, with a ceiling value of $1,157.31, for supply of Belbuca 300 mcg film 60s under firm fixed pricing. Place of performance is Conshohocken, PA. The ultimate completion date is March 26, 2026. No set-aside was used. The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical supply vehicle valued at $999,999,999 running through...